Home Tags Medical Research
Tag: Medical Research
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act...
AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
TAMPA, Fla. /Florida Newswire/ -- The C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.
VENTURA, Calif., Oct. 26, 2020 (SEND2PRESS NEWSWIRE) -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.
VENTURA, Calif., Oct. 7, 2020 (SEND2PRESS NEWSWIRE) -- Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer's disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).
NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor
CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
CAMBRIDGE, Mass., Sept. 2, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company's Scientific Advisory Board.
STONY BROOK, N.Y., July 20, 2020 (SEND2PRESSN NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster.
ROKiT Pharma’s Preclinical Studies Showing Tremendous Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards The Initiation Of Phase 1b/2...
LOS ANGELES, Calif., April 2, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
YAP, Micronesia, March 18, 2020 (SEND2PRESS NEWSWIRE) -- Schizophrenia may find a cure in individualized treatment. So says a new article in the science journal Holistic Nursing Practice. According to Dr. Daniel Helman, a researcher on the small island of Yap in Micronesia, long-term recovery is often possible, but appropriate studies are not being done.
DALLAS, Texas, March 10, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen Dallas County (Komen Dallas County) today said it has received bequests from the Estate of Edith Beutell and the Estate of Dr. Glenn Dodwell, which combined total more than $199,000. The gifts will further the organization's ability to assess the state of breast health in Dallas County and create plans of action to reduce breast cancer mortality disparities in the community.
SAN DIEGO, Calif., March 6, 2020 (SEND2PRESS NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with early Lyme disease from multiple endemic regions across the country.
ROSELAND, N.J., Feb. 27, 2020 (SEND2PRESS NEWSWIRE) -- The Sudden Unexplained Death in Childhood (SUDC) Foundation thanks Alabama, Arkansas, Florida, Georgia, Hawaii, Illinois, Iowa, Louisiana, Massachusetts, Mississippi, New Hampshire, New York, North Carolina, North Dakota, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, West Virginia for making statewide proclamations declaring March 2020 SUDC Awareness Month.
Susan G. Komen North Jersey Announces Award Honorees Robert C. Garrett, Amparo Aguirre and LAX For The Cure
PARSIPPANY, N.J., Feb. 18, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen® North Jersey today announced its Pink Tie Party honorees to be recognized during the March 21st event being held at Ruth's Chris Steak House in Jersey City. For over twenty years, Susan G. Komen North Jersey has helped those who can't pay for treatments, worked to ensure that all people get the care they need, fought for the rights of patients with policy makers and funded breakthroughs in research that saves lives.
CALNOC Announces the CALNOC Nightingale Research Fund: Raising Nursing’s Voice in Health Services Research
WALNUT CREEK, Calif., Jan, 7, 2020 (SEND2PRESS NEWSWIRE) -- CALNOC is pleased to introduce The CALNOC Nightingale Research Fund, an innovative and opportune resource in health services research focused on and administrated by nursing. We are excited to announce the Research Fund today in honor of Florence Nightingale and in celebration of the Year of the Nurse 2020.
CINCINNATI, Ohio, Nov. 22, 2019 (SEND2PRESS NEWSWIRE) -- The OLFACT Test Battery, developed by Osmic Enterprises, was initially developed to detect olfactory impairments. Now, it's been adapted as an automated, self-administered screening test to predict Alzheimer's disease/dementia and is being tested by a number of prominent physicians and research laboratories around the United States and in China.
SAN DIEGO, Calif., Nov. 22, 2019 (SEND2PRESS NEWSWIRE) -- SciScore announces the release of its innovative solution, the first and only working application of its kind, in support of the pre-clinical scientific research community's pursuit of reproducibility and transparency.
iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
NEW PORT RICHEY, Fla., Nov. 14, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation reemphasizes that the month of November is "C. diff. awareness month" and is being recognized with its partners around the globe again in 2019.
AUSTIN, Texas, Nov. 1, 2019 (SEND2PRESS NEWSWIRE) -- The National Deaf Chamber of Commerce (NDCOC), the first organization truly dedicated to advocating and protecting the interests of the Deaf business community, is pleased to announce its Board of Directors, Gina D'Amore, Michael Pimentel, Evan Winegard, and Jared Allebest.
NEW YORK, N.Y., Oct. 16, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance (LRA) is pleased to announce that seasoned professional Penny Mitchell has joined the organization as Senior Director of Marketing and Communications. In her new role, Ms. Mitchell will oversee the organization's strategic communications approach to leading lupus research worldwide and the value of participation by all sectors of the lupus community.